The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Dutasteride (Dutas (0.5 mg)) is a ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

This was a double-blind, randomized and placebo-controlled trial conducted at six centers in the USA. Two weeks after their screening visit, eligible men were randomized to receive dutasteride, 0.5 mg ...

January 24, 2012 — Dutasteride (Avodart, GlaxoSmithKline) has a potential role in the treatment of low-risk prostate cancer, according to the authors of the Reduction With Dutasteride of Clinical ...

Please provide your email address to receive an email when new articles are posted on . Daily treatments of dutasteride 0.5 mg were more effective than finasteride 1 mg daily or placebo in increasing ...

GlaxoSmithKline (GSK) announced today that the Swiss regulatory authority, Swissmedic, has granted approval for Duodart®, a fixed dose combination (FDC) of dutasteride (0.5mg) and tamsulosin (0.4mg).

Jalyn approved for benign prostatic hyperplasia (BPH) The FDA has approved GlaxoSmithKline's Jalyn, a fixed dose combination of dutasteride and tamsulosin, for the treatment of symptomatic benign ...

The purpose of this study was to determine the effect of dutasteride on quality of life of men with lower urinary tract symptoms associated with enlarged prostate or benign prostatic hyperplasia (BPH) ...

olaparib targets prostate cancer mutations In a study, use of the medication was associated with a significant 61% decreased risk. SAN DIEGO—Dutasteride use is associated with a decreased risk of ...

Dutasteride, a drug that is commonly used to treat enlargement of the prostate, might also slow the growth of early-stage prostate cancer and reduce the need for potentially debilitating treatments ...